The role of nasal carriage in Staphylococcus aureus infections

The Lancet Infectious Diseases - Tập 5 Số 12 - Trang 751-762 - 2005
Heiman Wertheim1, Damian C. Melles∗1, Martine De Vos1, Willem van Leeuwen1, Alex van Belkum1, Henri A. Verbrugh1, Jan Nouwen1
1Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, Netherlands.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Lowy, 1998, Staphylococcus aureus infections, N Engl J Med, 339, 520, 10.1056/NEJM199808203390806

Wertheim, 2004, Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use, J Hosp Infect, 56, 321, 10.1016/j.jhin.2004.01.026

2004, Vancomycin-resistant Staphylococcus aureus—New York, 2004, MMWR Morb Mortal Wkly Rep, 53, 322

Solberg, 1965, A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimations, Acta Med Scand Suppl, 436, 1

Williams, 1963, Healthy carriage of Staphylococcus aureus: its prevalence and importance, Bacteriol Rev, 27, 56, 10.1128/MMBR.27.1.56-71.1963

Kluytmans, 1997, Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks, Clin Microbiol Rev, 10, 505, 10.1128/CMR.10.3.505

Wertheim, 2004, Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers, Lancet, 364, 703, 10.1016/S0140-6736(04)16897-9

von Eiff, 2001, Nasal carriage as a source of Staphylococcus aureus bacteremia, N Engl J Med, 344, 11, 10.1056/NEJM200101043440102

Perl, 2002, Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections, N Engl J Med, 346, 1871, 10.1056/NEJMoa003069

Valentine, 1952, Superficial staphylococcal infection, Lancet, 2, 351, 10.1016/S0140-6736(52)92245-9

Kluytmans, 2005, Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections, Infection, 33, 3, 10.1007/s15010-005-4012-9

Ogston, 1881, Report upon micro-organisms in surgical diseases, BMJ, 1, 369, 10.1136/bmj.1.1054.369

Fisk, 1944, Studies on staphylococci. III Further observations on bacteriophage typing of Staphylococcus aureus, Am J Hyg, 40, 232

Barber, 1947, Staphylococcal infection due to penicillin-resistant strains, Br Med J, 2, 863, 10.1136/bmj.2.4534.863

Atkins, 1952, The role of staphylococcal infection in beat disorders of miners, Br J Ind Med, 9, 296

Jevons, 1961, “Celbenin”-resistant staphylococi, Br Med J, 2, 124, 10.1136/bmj.1.5219.124-a

Prevost, 1991, Pulsed field gel electrophoresis as a new epidemiological tool for monitoring methicillin-resistant Staphylococcus aureus in an intensive care unit, J Hosp Infect, 17, 255, 10.1016/0195-6701(91)90270-I

Patti, 1994, MSCRAMM-mediated adherence of microorganisms to host tissues, Annu Rev Microbiol, 48, 585, 10.1146/annurev.mi.48.100194.003101

Enright, 2000, Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus, J Clin Microbiol, 38, 1008, 10.1128/JCM.38.3.1008-1015.2000

Kuroda, 2001, Whole genome sequencing of meticillin-resistant Staphylococcus aureus, Lancet, 357, 1225, 10.1016/S0140-6736(00)04403-2

Chambers, 2001, The changing epidemiology of Staphylococcus aureus?, Emerg Infect Dis, 7, 178, 10.3201/eid0702.010204

Chang, 2003, Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene, N Engl J Med, 348, 1342, 10.1056/NEJMoa025025

Armstrong-Esther, 1976, Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children, Ann Hum Biol, 3, 221, 10.1080/03014467600001381

Wertheim, 2005, Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults, Antimicrob Agents Chemother, 49, 1465, 10.1128/AAC.49.4.1465-1467.2005

Ridley, 1959, Perineal carriage of Staph. aureus, Br Med J, 34, 270, 10.1136/bmj.1.5117.270

Rimland, 1986, Gastrointestinal carriage of methicillin-resistant Staphylococcus aureus, J Clin Microbiol, 24, 137, 10.1128/JCM.24.1.137-138.1986

Guinan, 1982, Vaginal colonization with Staphylococcus aureus in healthy women: a review of four studies, Ann Intern Med, 96, 944, 10.7326/0003-4819-96-6-944

Dancer, 1991, Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin, J Clin Pathol, 44, 681, 10.1136/jcp.44.8.681

Eriksen, 1995, Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period, Epidemiol Infect, 115, 51, 10.1017/S0950268800058118

VandenBergh, 1999, Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state, J Clin Microbiol, 37, 3133, 10.1128/JCM.37.10.3133-3140.1999

Maxwell, 1969, Long-term study of nasal staphylococci among hospital personnel, Am J Surg, 118, 849, 10.1016/0002-9610(69)90245-1

White, 1963, Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci, Antimicrobial Agents Chemother, 161, 667

Nouwen, 2005, Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections, Kidney Int, 67, 1084, 10.1111/j.1523-1755.2005.00174.x

Nouwen, 2004, Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a “culture rule”, Clin Infect Dis, 39, 806, 10.1086/423376

Hu, 1995, Typing of Staphylococcus aureus colonising human nasal carriers by pulsed-field gel electrophoresis, J Med Microbiol, 42, 127, 10.1099/00222615-42-2-127

Cunliffe, 1949, Incidence of Staph. aureus in the anterior nares of healthy children, Lancet, 2, 411, 10.1016/S0140-6736(49)90118-X

Noble, 1967, Carriage of Staphylococcus aureus in random samples of a normal population, J Hyg (Lond), 65, 567, 10.1017/S002217240004609X

Peacock, 2003, Determinants of acquisition and carriage of Staphylococcus aureus in infancy, J Clin Microbiol, 41, 5718, 10.1128/JCM.41.12.5718-5725.2003

Shopsin, 2000, Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community, J Infect Dis, 182, 359, 10.1086/315695

Cole, 2001, Determinants of Staphylococcus aureus nasal carriage, Clin Diagn Lab Immunol, 8, 1064, 10.1128/CDLI.8.6.1064-1069.2001

Yazgi, 2003, Nasal carriage of Staphylococcus aureus in hospital personnel and the normal population and antibiotic resistance of the isolates, Mikrobiyol Bul, 37, 137

Kenner, 2003, Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population, Infect Control Hosp Epidemiol, 24, 439, 10.1086/502229

Bischoff, 2004, Staphylococcus aureus nasal carriage in a student community: prevalence, clonal relationships, and risk factors, Infect Control Hosp Epidemiol, 25, 485, 10.1086/502427

Anwar, 2004, Staphylococcus aureus and MRSA nasal carriage in general population, J Coll Physicians Surg Pak, 14, 661

Leman, 2004, Nasal carriage of methicillin-resistant Staphylococcus aureus in an American Indian population, Infect Control Hosp Epidemiol, 25, 121, 10.1086/502361

Nulens, 2005, Staphylococcus aureus carriage among participants at the 13th European Congress of Clinical Microbiology and Infectious Diseases, Eur J Clin Microbiol Infect Dis, 24, 145, 10.1007/s10096-004-1258-6

Bagger, 2004, Postoperative infection with meticillin-resistant Staphylococcus aureus and socioeconomic background, Lancet, 363, 706, 10.1016/S0140-6736(04)15647-X

Bogaert, 2004, Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children, Lancet, 363, 1871, 10.1016/S0140-6736(04)16357-5

Squier, 2002, Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit, Infect Control Hosp Epidemiol, 23, 495, 10.1086/502095

Nouwen, 2004, Human factor in Staphylococcus aureus nasal carriage, Infect Immun, 72, 6685, 10.1128/IAI.72.11.6685-6688.2004

Herwaldt, 2004, Preoperative risk factors for nasal carriage of Staphylococcus aureus, Infect Control Hosp Epidemiol, 25, 481, 10.1086/502426

Parnaby, 1996, Carriage of Staphylococcus aureus in the elderly, J Hosp Infect, 33, 201, 10.1016/S0195-6701(96)90003-1

Lipsky, 1987, Factors affecting staphylococcal colonization among NIDDM outpatients, Diabetes Care, 10, 483, 10.2337/diacare.10.4.483

Yu, 1986, Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis, N Engl J Med, 315, 91, 10.1056/NEJM198607103150204

Kirmani, 1978, Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis, Arch Intern Med, 138, 1657, 10.1001/archinte.1978.03630360041019

Luzar, 1990, Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis, N Engl J Med, 322, 505, 10.1056/NEJM199002223220804

Chapoutot, 1999, Staphylococcus aureus nasal carriage in 104 cirrhotic and control patients. A prospective study, J Hepatol, 30, 249, 10.1016/S0168-8278(99)80070-1

Chang, 1998, Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients, Transplantation, 65, 1169, 10.1097/00007890-199805150-00004

Nguyen, 1999, Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients, Ann Intern Med, 130, 221, 10.7326/0003-4819-130-3-199902020-00026

Sissolak, 2002, Risk factors for nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains, Eur J Clin Microbiol Infect Dis, 21, 88, 10.1007/s10096-001-0666-0

Williams, 1998, S. aureus isolation from the lesions, the hands, and the anterior nares of patients with atopic dermatitis, Pediatr Dermatol, 15, 194, 10.1046/j.1525-1470.1998.1998015194.x

Steele, 1980, Recurrent staphylococcal infection in families, Arch Dermatol, 116, 189, 10.1001/archderm.1980.01640260065016

Hoeger, 1992, Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains, J Infect Dis, 165, 1064, 10.1093/infdis/165.6.1064

Boyko, 1989, NIDDM and prevalence of nasal Staphylococcus aureus colonization, Diabetes Care, 12, 189, 10.2337/diacare.12.3.189

Crossley, 1997

Wertheim HFL, Kleef M, Vos MC, Ott A, Verbrugh H, Fokkens W. Nosepicking and nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol (in press).

Gluck, 2000, The nose as bacterial reservoir: important differences between the vestibule and cavity, Laryngoscope, 110, 426, 10.1097/00005537-200003000-00019

Solberg, 2000, Spread of Staphylococcus aureus in hospitals: causes and prevention, Scand J Infect Dis, 32, 587, 10.1080/003655400459478

Sherertz, 2001, “Cloud” health-care workers, Emerg Infect Dis, 7, 241, 10.3201/eid0702.010218

Goslings, 1958, Nasal carrier rate of antibiotic-resistant staphylococci; influence of hospitalization on carrier rate in patients, and their household contacts, AMA Arch Intern Med, 102, 691, 10.1001/archinte.1958.00260220007002

Nouwen, 2004

Wagenvoort, 2005, Risk of re-introduction of methicillin-resistant Staphylococcus aureus into the hospital by intrafamilial spread from and to healthcare workers, J Hosp Infect, 59, 67, 10.1016/j.jhin.2004.07.025

Herwaldt, 2003, Sources of Staphylococcus aureus for patients on continuous ambulatory peritoneal dialysis, Perit Dial Int, 23, 237, 10.1177/089686080302300304

Decker, 1986, An outbreak of staphylococcal skin infections among river rafting guides, Am J Epidemiol, 124, 969, 10.1093/oxfordjournals.aje.a114486

Kazakova, 2005, A clone of methicillin-resistant Staphylococcus aureus among professional football players, N Engl J Med, 352, 468, 10.1056/NEJMoa042859

Armand-Lefevre, 2005, Clonal comparison of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs, Emerg Infect Dis, 11, 711, 10.3201/eid1105.040866

Bassetti, 2004, Carriage of among injection drug users: lower prevalence in an injection heroin maintenance program than in an oral methadone program, Infect Control Hosp Epidemiol, 25, 133, 10.1086/502364

Miles, 1944, The carriage of Staphylococcus (pyogenes) aureus in man and its relation to wound infection, J Pathol Bacteriol, 56, 513, 10.1002/path.1700560405

Noble, 1964, Some aspects of nasal carriage of staphylococci, J Clin Pathol, 17, 79, 10.1136/jcp.17.1.79

Kaliner, 1991, Human nasal respiratory secretions and host defense, Am Rev Respir Dis, 144, S52, 10.1164/ajrccm/144.3_pt_2.S52

Cole, 1999, Innate antimicrobial activity of nasal secretions, Infect Immun, 67, 3267, 10.1128/IAI.67.7.3267-3275.1999

von Aulock, 2003, Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment, Immunobiology, 208, 413, 10.1078/0171-2985-00285

Pickkers, 2004, Hypothesis: normalisation of cytokine dysbalance explains the favourable effects of strict glucose regulation in the critically ill, Neth J Med, 62, 143

Nagaoka, 2000, Synergistic actions of antibacterial neutrophil defensins and cathelicidins, Inflamm Res, 49, 73, 10.1007/s000110050561

Ong, 2002, Endogenous antimicrobial peptides and skin infections in atopic dermatitis, N Engl J Med, 347, 1151, 10.1056/NEJMoa021481

Peschel, 2002, How do bacteria resist human antimicrobial peptides?, Trends Microbiol, 10, 179, 10.1016/S0966-842X(02)02333-8

Jin, 2004, Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism, J Immunol, 172, 1169, 10.4049/jimmunol.172.2.1169

Peschel, 2001, Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine, J Exp Med, 193, 1067, 10.1084/jem.193.9.1067

Kristian, 2003, MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing, Infect Immun, 71, 546, 10.1128/IAI.71.1.546-549.2003

Bera, 2005, Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus, Mol Microbiol, 55, 778, 10.1111/j.1365-2958.2004.04446.x

Ritz, 1984, Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen-producing strains of Staphylococcus aureus, Infect Immun, 43, 954, 10.1128/IAI.43.3.954-958.1984

Krstic, 1991

Shuter, 1996, Staphylococcus aureus binding to human nasal mucin, Infect Immun, 64, 310, 10.1128/IAI.64.1.310-318.1996

Aly, 1977, Bacterial adherence to nasal mucosal cells, Infect Immun, 17, 546, 10.1128/IAI.17.3.546-549.1977

Aly, 1980, Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells, J Infect Dis, 141, 463, 10.1093/infdis/141.4.463

Bibel, 1982, Importance of the keratinized epithelial cell in bacterial adherence, J Invest Dermatol, 79, 250, 10.1111/1523-1747.ep12500072

Hare, 1958, Further studies on the transmission of Staph. aureus, Br Med J, 29, 69, 10.1136/bmj.1.5062.69

O'Brien, 2002, Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization, Cell Microbiol, 4, 759, 10.1046/j.1462-5822.2002.00231.x

Roche, 2003, The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells, Microbiology, 149, 2759, 10.1099/mic.0.26412-0

Weidenmaier, 2004, Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections, Nat Med, 10, 243, 10.1038/nm991

Bibel, 1983, Competitive adherence as a mechanism of bacterial interference, Can J Microbiol, 29, 700, 10.1139/m83-114

Shinefield, 1966, Interactions of staphylococcal colonization. Influence of normal nasal flora and antimicrobials on inoculated Staphylococcus aureus strain 502A, Am J Dis Child, 111, 11, 10.1001/archpedi.1966.02090040047002

Lina, 2003, Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles, Appl Environ Microbiol, 69, 18, 10.1128/AEM.69.1.18-23.2003

van Leeuwen, 2000, Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide, J Bacteriol, 182, 5721, 10.1128/JB.182.20.5721-5729.2000

Strauss, 1969, Bacterial interference treatment of recurrent furunculosis. 2. Demonstration of the relationship of strain to pathogenicity, JAMA, 208, 861, 10.1001/jama.1969.03160050115019

Houck, 1972, Fatal septicemia due to Staphylococcus aureus 502A. Report of a case and review of the infectious complications of bacterial interference programs, Am J Dis Child, 123, 45, 10.1001/archpedi.1972.02110070095012

Musser, 1992, Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination, J Clin Microbiol, 30, 2058, 10.1128/JCM.30.8.2058-2063.1992

Grundmann, 2002, Determining the genetic structure of the natural population of Staphylococcus aureus: a comparison of multilocus sequence typing with pulsed-field gel electrophoresis, randomly amplified polymorphic DNA analysis, and phage typing, J Clin Microbiol, 40, 4544, 10.1128/JCM.40.12.4544-4546.2002

Feil, 2003, How clonal is Staphylococcus aureus?, J Bacteriol, 185, 3307, 10.1128/JB.185.11.3307-3316.2003

Melles, 2004, Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus, J Clin Invest, 114, 1732, 10.1172/JCI200423083

Feil, 2000, Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data, Genetics, 154, 1439, 10.1093/genetics/154.4.1439

Robinson, 2004, Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus, Clin Microbiol Infect, 10, 92, 10.1111/j.1469-0691.2004.00768.x

Feil, 2004, eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data, J Bacteriol, 186, 1518, 10.1128/JB.186.5.1518-1530.2004

Enright, 2002, The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA), Proc Natl Acad Sci USA, 99, 7687, 10.1073/pnas.122108599

Fitzgerald, 2001, Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic, Proc Natl Acad Sci USA, 98, 8821, 10.1073/pnas.161098098

Robinson, 2005, Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone, Lancet, 365, 1256, 10.1016/S0140-6736(05)74814-5

Pan, 2005, Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus—and their relation to community-associated disease activity, J Infect Dis, 192, 811, 10.1086/432072

Foster, 2004, The Staphylococcus aureus “superbug”, J Clin Invest, 114, 1693, 10.1172/JCI200423825

Wertheim, 2005, Associations between Staphylococcus aureus genotype, infection, and in-hospital mortality: a nested case-control study, J Infect Dis, 192, 1196, 10.1086/444427

Peacock, 2002, Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus, Infect Immun, 70, 4987, 10.1128/IAI.70.9.4987-4996.2002

Smith, 1994, Staphylococcus aureus carriage and HIV-1 disease: association with increased mucocutaneous infections as well as deep soft-tissue infections and sepsis, Arch Dermatol, 130, 521, 10.1001/archderm.130.4.521

Tulloch, 1954, Nasal carriage in staphylococcal skin infections, Br Med J, 4893, 912, 10.1136/bmj.2.4893.912

Toshkova, 2001, The significance of nasal carriage of Staphylococcus aureus as risk factor for human skin infections, FEMS Microbiol Lett, 202, 17, 10.1111/j.1574-6968.2001.tb10774.x

Barrow, 1955, Clinical and bacteriological aspects of impetigo contagiosa, J Hyg (Lond), 53, 495, 10.1017/S0022172400000991

Hobbs, 1947, Sycosis barbae, Lancet, 2, 572, 10.1016/S0140-6736(47)91578-X

Copeman, 1958, Treatment of recurrent styes, Lancet, 2, 728, 10.1016/S0140-6736(58)91337-0

Laupland, 2004, Severe bloodstream infections: a population-based assessment, Crit Care Med, 32, 992, 10.1097/01.CCM.0000119424.31648.1E

Espersen, 1995, Identifying the patient risk for Staphylococcus aureus bloodstream infections, J Chemother, 7, 11

Roder, 1999, Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark, Arch Intern Med, 159, 462, 10.1001/archinte.159.5.462

Fridkin, 2005, Methicillin-resistant Staphylococcus aureus disease in three communities, N Engl J Med, 352, 1436, 10.1056/NEJMoa043252

Vandenesch, 2003, Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence, Emerg Infect Dis, 9, 978, 10.3201/eid0908.030089

Salgado, 2003, Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors, Clin Infect Dis, 36, 131, 10.1086/345436

Faria, 2005, Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection, J Clin Microbiol, 43, 1836, 10.1128/JCM.43.4.1836-1842.2005

Ellis, 2004, Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers, Clin Infect Dis, 39, 971, 10.1086/423965

Wisplinghoff, 2004, Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin Infect Dis, 39, 309, 10.1086/421946

VandenBergh, 1996, Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery, Infect Control Hosp Epidemiol, 17, 786, 10.2307/30141171

Pittet, 1995, Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths, Arch Intern Med, 155, 1177, 10.1001/archinte.1995.00430110089009

Abramson, 1999, Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?, Infect Control Hosp Epidemiol, 20, 408, 10.1086/501641

Kirkland, 1999, The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs, Infect Control Hosp Epidemiol, 20, 725, 10.1086/501572

Cespedes, 2005, The clonality of Staphylococcus aureus nasal carriage, J Infect Dis, 191, 444, 10.1086/427240

Davis, 2004, Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection, Clin Infect Dis, 39, 776, 10.1086/422997

Kalmeijer, 2000, Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery, Infect Control Hosp Epidemiol, 21, 319, 10.1086/501763

Kluytmans, 1995, Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery, J Infect Dis, 171, 216, 10.1093/infdis/171.1.216

Ruef, 1996, Sternal wound infection after heart operations in pediatric patients associated with nasal carriage of Staphylococcus aureus, J Thorac Cardiovasc Surg, 112, 681, 10.1016/S0022-5223(96)70052-1

Kaplowitz, 1988, Prospective study of microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients, J Clin Microbiol, 26, 1257, 10.1128/JCM.26.7.1257-1262.1988

Rebel, 1975, The flora of renal haemodialysis shunt sites, J Clin Pathol, 28, 29, 10.1136/jcp.28.1.29

Chang, 1998, Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection, Infect Control Hosp Epidemiol, 19, 328, 10.2307/30141373

Desai, 2003, Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation, Liver Transpl, 9, 754, 10.1053/jlts.2003.50142

Bert, 2000, Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients, Clin Infect Dis, 31, 1295, 10.1086/317469

Pujol, 1996, Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains, Am J Med, 100, 509, 10.1016/S0002-9343(96)00014-9

Corbella, 1997, Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients, Eur J Clin Microbiol Infect Dis, 16, 351, 10.1007/BF01726362

Garrouste-Orgeas, 2001, Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use, Infect Control Hosp Epidemiol, 22, 687, 10.1086/501846

Jensen, 1999, Risk factors for hospital-acquired Staphylococcus aureus bacteremia, Arch Intern Med, 159, 1437, 10.1001/archinte.159.13.1437

Richards, 2000, Nosocomial infections in combined medical-surgical intensive care units in the United States, Infect Control Hosp Epidemiol, 21, 510, 10.1086/501795

Nielsen, 1998, Dialysis catheter-related septicaemia—focus on Staphylococcus aureus septicaemia, Nephrol Dial Transplant, 13, 2847, 10.1093/ndt/13.11.2847

Goldblum, 1982, Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of Staphylococcal carriage, Am J Kidney Dis, 2, 281, 10.1016/S0272-6386(82)80075-9

Boelaert, 1991, The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness, J Hosp Infect, 19, 41, 10.1016/0195-6701(91)90202-J

Boelaert, 1993, Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients, Nephrol Dial Transplant, 8, 235

Bloom, 1996, Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis, Am J Kidney Dis, 27, 687, 10.1016/S0272-6386(96)90104-3

Kluytmans, 1996, Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients, Infect Control Hosp Epidemiol, 17, 793, 10.2307/30141172

Johnson, 2002, A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters, Nephrol Dial Transplant, 17, 1802, 10.1093/ndt/17.10.1802

Davies, 1989, Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD), Perit Dial Int, 9, 61, 10.1177/089686088900900112

Sesso, 1989, Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis, Clin Nephrol, 31, 264

Lye, 1994, Staphylococcus aureus CAPD-related infections are associated with nasal carriage, Adv Perit Dial, 10, 163

Wanten, 1996, Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study, Perit Dial Int, 16, 352, 10.1177/089686089601600405

Zimakoff, 1996, Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark, J Hosp Infect, 33, 289, 10.1016/S0195-6701(96)90015-8

Perez-Fontan, 1992, Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin, Adv Perit Dial, 8, 242

Thodis, 1998, Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site, Perit Dial Int, 18, 261

Mylotte, 1999, “Pulse” nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis, Infect Control Hosp Epidemiol, 20, 741, 10.1086/501575

Thodis, 2000, The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis, Adv Perit Dial, 16, 257

Hanslik, 1994, Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage, Adv Perit Dial, 10, 158

Araki, 2003, Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis, Perit Dial Int, 23, 267, 10.1177/089686080302300309

Conly, 2002, Increasing mupirocin resistance of Staphylococcus aureus in CAPD—should it continue to be used as prophylaxis?, Perit Dial Int, 22, 649, 10.1177/089686080202200601

White, 1963, Nasal reservoir as the source of extranasal staphylococci, Antimicrobial Agents Chemother, 161, 679

Henderson, 1961, Nasal disinfection in prevention of post-operative staphylococcal infection of wounds, Br Med J, 5248, 330, 10.1136/bmj.2.5248.330

Elek, 1957, The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection, Br J Exp Pathol, 38, 573

Kluytmans, 1996, Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus, Infect Control Hosp Epidemiol, 17, 780, 10.2307/30141170

Cimochowski, 2001, Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics, Ann Thorac Surg, 71, 1572, 10.1016/S0003-4975(01)02519-X

Gernaat-van der Sluis, 1998, Prophylactic mupirocin could reduce orthopedic wound infections. 1,044 patients treated with mupirocin compared with 1,260 historical controls, Acta Orthop Scand, 69, 412, 10.3109/17453679808999058

Wertheim, 2004, Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study, Ann Intern Med, 140, 419, 10.7326/0003-4819-140-6-200403160-00007

Kalmeijer, 2002, Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study, Clin Infect Dis, 35, 353, 10.1086/341025

Blok, 2003, Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital, Infect Control Hosp Epidemiol, 24, 679, 10.1086/502275

Hoeksma, 1963, The normal flora of the nose in twins, Acta Leiden, 32, 123

Aly, 1974, Staphylococcus aureus carriage in twins, Am J Dis Child, 127, 486